David? ; - )Spectral has no history of marketting (selling) PMX in Canada even when it has been approved since 2011. The trial result as disclosed so far demonstrated the least efficacy of all the successful trials. (Only the failed French one is worse). It is overly promotional and optimistic to use the applicable market size to predict the sp. It does no realistically describe the risk/reward for this company stock